Getinge reports profit growth for third quarter 2026

Medical technology company Getinge reported organic growth in both order intake and net sales for the third quarter of 2026. The results signal a period of operational consolidation, with the firm citing improved margins and cash flow as key performance drivers during the July-September period.

CEO Mattias Perjos attributed the performance to disciplined execution and steady demand for the company’s medical equipment. By focusing on internal efficiency and addressing supply chain requirements, the firm has managed to bolster its bottom line despite broader economic volatility in the healthcare sector.

Looking forward, Getinge maintains its focus on sustaining this momentum. As the company navigates the competitive landscape for surgical and intensive care technologies, analysts are watching how the firm translates these quarterly gains into long-term market stability.